Tenghua Yu

Jiangxi Key Laboratory Of Oncology, Jiangxi Health Commission Key Laboratory Of Tumor Microenvironment And Immunoregulation, Jiangxi Key Laboratory Of Tumor Metastasis Of Jiangxi Health Commission
Nanchang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Development of a nomogram for predicting axillary pathologic complete response after neoadjuvant therapy in clinically node-positive breast cancer.

Development of a nomogram for predicting axillary pathologic complete response after neoadjuvant therapy in clinically node-positive breast cancer.

Journal: Frontiers in oncology

Published: July 14, 2026

Early identification of neoadjuvant therapy non-response via multimodal immune-imaging biomarkers in breast cancer.

Early identification of neoadjuvant therapy non-response via multimodal immune-imaging biomarkers in breast cancer.

Journal: Frontiers in immunology

Published: May 10, 2026

Knowledge and attitudes among high school students toward medical misinformation and their willingness to pursue medical-related majors.

Knowledge and attitudes among high school students toward medical misinformation and their willingness to pursue medical-related majors.

Journal: Medicine

Published: January 09, 2026

The versatile role of GPER in metabolic homeostasis and disease

The versatile role of GPER in metabolic homeostasis and disease

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

Published: December 24, 2025

Predicting response to neoadjuvant therapy in breast cancer using longitudinal DCE-MRI deep learning integrated with tumor microenvironment data.

Predicting response to neoadjuvant therapy in breast cancer using longitudinal DCE-MRI deep learning integrated with tumor microenvironment data.

Journal: Frontiers in immunology

Published: November 19, 2025

YB-1 drives triple-negative breast cancer progression and paclitaxel resistance through Wnt/β-catenin pathway.

YB-1 drives triple-negative breast cancer progression and paclitaxel resistance through Wnt/β-catenin pathway.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: September 24, 2025

Fungal Colonization by Malassezia globosa Promotes Breast Cancer Progression and M2 Macrophage Polarization Through the MBL-C3a-C3aR Signaling Pathway.

Fungal Colonization by Malassezia globosa Promotes Breast Cancer Progression and M2 Macrophage Polarization Through the MBL-C3a-C3aR Signaling Pathway.

Journal: MicrobiologyOpen

Published: August 20, 2025

Six-year retrospective analysis of the epidemiology and risk factors of multidrug-resistant bloodstream infections in oncology patients in Jiangxi, China.

Six-year retrospective analysis of the epidemiology and risk factors of multidrug-resistant bloodstream infections in oncology patients in Jiangxi, China.

Journal: Microbiology spectrum

Published: August 14, 2025

Significance of SUMOylation in breast cancer progression: a comprehensive investigation using single-cell analysis and bioinformatics.

Significance of SUMOylation in breast cancer progression: a comprehensive investigation using single-cell analysis and bioinformatics.

Journal: Frontiers in immunology

Published: July 29, 2025

GPER in metabolic homeostasis and disease: molecular mechanisms, nutritional regulation, and therapeutic potential.

GPER in metabolic homeostasis and disease: molecular mechanisms, nutritional regulation, and therapeutic potential.

Journal: Journal of translational medicine

Published: May 31, 2025

Mechanistic insights into SENP1 and OCT4 interaction in promoting drug resistance and stem cell features in colon cancer.

Mechanistic insights into SENP1 and OCT4 interaction in promoting drug resistance and stem cell features in colon cancer.

Journal: American journal of physiology. Cell physiology

Published: March 10, 2025

Endocrine therapy resistance of breast cancer: Important role of G protein-coupled estrogen receptor (GPER) and new therapeutic strategies.

Endocrine therapy resistance of breast cancer: Important role of G protein-coupled estrogen receptor (GPER) and new therapeutic strategies.

Journal: Genes & diseases

Published: December 13, 2024

Showing 1-12 of 38

Last Updated: 09/26/2026